Kolexia
Bourhis Francois Gastro-entérologie
Bourhis Francois
Gastro-entérologie
Hôpital Chambéry
Chambéry, France
47 Activités
25 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Varicelle Algie post-zona Hépatite C chronique Herpès Zona Hémorragie Myélome multiple

Collaborateurs

Voir plus
Berthelet Olivier
Berthelet Olivier
Hôpital Chambéry, Chambéry, France
Lecoq Laetitia
Lecoq Laetitia
Hôpital Chambéry, Chambéry, France
Heluwaert Frederic
Heluwaert Frederic
Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France
Fontanges Thierry
Fontanges Thierry
Hôpital Edouard Herriot, Lyon, France

Industries

Voir plus
A+A
18 collaboration(s)
Dernière en 2023
B3TSI
8 collaboration(s)
Dernière en 2023
Abbvie
4 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Effectiveness and Safety of Rabbit Anti-Thymocyte Globulin Versus Non-Anti-Thymocyte Globulin Regimens for Graft-Versus-Host Disease Prophylaxis: A Systematic Review and Meta-Analysis
65th ASH Annual Meeting Abstracts   02 novembre 2023
Re: Arcuri and Americo "Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis".
Annals of hematology   18 février 2022
Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 inactivated varicella-zoster vaccine (ZV ) trial.
Expert review of pharmacoeconomics & outcomes research   18 novembre 2019
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001): A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (HCTs)
Essai Clinique (Merck & Co.)   10 septembre 2019
Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH).
Presse medicale (Paris, France : 1983)   08 mars 2019
Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis.
Rheumatology (Oxford, England)   21 août 2017
Middle-term mortality and re-bleeding after initial diverticular bleeding: A nationwide study of 365 mostly elderly French patients.
United European gastroenterology journal   23 juin 2016
Simeprevir plus sofosbuvir for the treatment of hepatitis C genotype 1 and 4 in a French multicenter cohort in real life: ReaL-SimSof study
The 66th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2015   07 octobre 2015
P0796 : New direct acting antivirals for hepatitis C treatment: first results in a real-life setting in France
Abstracts of The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver   01 avril 2015
P0810 : Sofosbuvir and daclatasvir combined treatment for chronic hepatitis C: First-year efficacy and safety data in a real-life setting
Abstracts of The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver   01 avril 2015